PACB's strong Q4 results, expanding sequencing tech portfolio and rising system adoption highlight growth momentum despite ...
MENLO PARK, Calif., Sept. 22, 2025 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, today announced its entry into the ...
(RTTNews) - PacBio (PACB), a developer of highly accurate sequencing solutions, is slated to participate in several upcoming investor conferences this month, underscoring its visibility within the ...
Zacks Investment Research on MSN
Pacific Biosciences of California (PACB) laps the stock market: Here's why
Pacific Biosciences of California (PACB) ended the recent trading session at $1.44, demonstrating a +1.41% change from the preceding day's closing price. The stock's change was more than the S&P 500's ...
Zacks Investment Research on MSN
PacBio wins Basecamp Research deal for Trillion Gene Atlas initiative
Pacific Biosciences of California, Inc. PACB, popularly known as PacBio, recently announced that Basecamp Research has ...
PacBio reports that through its partnership with China-headquartered Berry Genomics, the Sequel II CNDx system has received Class III Medical Device Registration approval from the National Medical ...
MENLO PARK, Calif., March 05, 2026 (GLOBE NEWSWIRE) -- PacBio (PACB), a leading provider of high-quality, long-read sequencing technologies, today announced the appointment of Christopher Gibson, Ph.D ...
A number of stocks fell in the afternoon session after the February jobs report revealed an unexpected contraction in employment, with the healthcare industry showing significant job losses. According ...
Pacific Biosciences of California, Inc. PACB, popularly known as PacBio, has been gaining from its continued product development. The optimism, led by strong third-quarter results, is expected to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results